Novel PET Imaging in Prostate Cancer
Evan Y. Yu, MD, discusses the role of PET imaging in prostate cancer.
Evan Y. Yu, MD, associate professor, Department of Medicine, Division of Oncology, Seattle Cancer Care Alliance, discusses the role of PET imaging in prostate cancer.
Clinical Pearls:
- Various types of PET imaging can be used to help detect prostate cancer and measure prostate cancer treatment responses
- A study that explored sodium fluoride PET as a marker in treatment response with dasatinib showed a longer progression-free survival
- PET imaging showed that ARN-509 was hitting its intended target and helped researchers determine the optimal biologic dosing for the agent
- Using PET imaging in clinical trials will help researchers get a better understanding the mechanism of action of some novel agents
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More
Systemic Therapy Choice Linked to Radiosurgery Outcomes in Brain Mets
December 6th 2024In an interview with Targeted OncologyT, Rupesh Kotecha, MD, discussed a study focused on how systemic therapy selection impacts outcomes in patients with brain metastases, particularly those with lung cancer.
Read More
